SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 524 filers reported holding SEAGEN INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,487,870 | +10.3% | 530,228 | +0.1% | 0.80% | +8.1% |
| Q2 2023 | $101,961,266 | -5.3% | 529,779 | -8.3% | 0.74% | -1.3% |
| Q1 2023 | $107,645,132 | +3.7% | 577,620 | -28.5% | 0.75% | +6.7% |
| Q4 2022 | $103,814,767 | +2.5% | 807,872 | +9.2% | 0.70% | -1.8% |
| Q3 2022 | $101,264,000 | -26.4% | 740,028 | -4.9% | 0.71% | -37.1% |
| Q2 2022 | $137,661,000 | +7.9% | 778,045 | -12.2% | 1.13% | +30.6% |
| Q1 2022 | $127,605,000 | -7.1% | 885,876 | -0.3% | 0.87% | -1.0% |
| Q4 2021 | $137,385,000 | -8.7% | 888,647 | +0.3% | 0.88% | -14.3% |
| Q3 2021 | $150,440,000 | +13.2% | 886,024 | +5.3% | 1.02% | +12.4% |
| Q2 2021 | $132,906,000 | +54.1% | 841,817 | +64.2% | 0.91% | +26.7% |
| Q1 2021 | $86,245,000 | -3.9% | 512,657 | +0.0% | 0.72% | +1.0% |
| Q4 2020 | $89,788,000 | – | 512,643 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |